ETS GENE TRANSLOCATIONS AND PROSTATE CANCER PROGNOSIS

被引：0
|
作者：
Clark, J.
Attard, G.
Ambroisine, L.
Mills, I. G.
Fisher, G.
Flohr, P.
Reid, A.
Edwards, S.
Kovacs, G.
Berney, D.
Foster, C.
Massie, C. E.
Fletcher, A.
De Bono, J. S.
Scardino, P.
Cuzick, J.
Cooper, C. S.
机构：
来源：
ANTICANCER RESEARCH | 2008年 / 28卷 / 6B期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
762
引用
收藏
页码：4155 / 4156
页数：2
相关论文
共 50 条
  • [41] Endosomal gene expression: a new indicator for prostate cancer patient prognosis?
    Johnson, Ian R. D.
    Parkinson-Lawrence, Emma J.
    Keegan, Helen
    Spillane, Cathy D.
    Barry-O'Crowley, Jacqui
    Watson, William R.
    Selemidis, Stavros
    Butler, Lisa M.
    O'Leary, John J.
    Brooks, Doug A.
    ONCOTARGET, 2015, 6 (35) : 37919 - 37929
  • [42] A 23-Gene Classifier urine test for prostate cancer prognosis
    Guo, Jinan
    Johnson, Heather
    Zhang, Xuhui
    Feng, Xiaoyan
    Zhang, Heqiu
    Simoulis, Athanasios
    Wu, Alan H. B.
    Xia, Taolin
    Li, Fei
    Tan, Wanlong
    Johnson, Allan
    Dizeyi, Nishtman
    Abrahamsson, Per-Anders
    Kenner, Lukas
    Chen, Lingwu
    Zhong, Wanmei
    Xiao, Kefeng
    Persson, Jenny L.
    Zou, Chang
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (03):
  • [43] Mapping chromosome translocations in prostate cancer cell lines
    Strafford, J
    LeRoux, L
    Lane, TM
    Young, BD
    Oliver, RTD
    JOURNAL OF MEDICAL GENETICS, 2002, 39 : S50 - S50
  • [44] Loss of function mutations of an ETS repressor expand the ETS positive subset of prostate cancer
    Bose, Rohit
    Abida, Wassim
    Karthaus, Wouter
    Armenia, Joshua
    Iaquinta, Phillip
    Wongvipat, John
    Doran, Michael
    Hieronymus, Haley
    Watson, Philip
    Sullivan, Patrick
    Liang, Yupu
    Schultz, Nikolaus
    Sawyers, Charles
    CANCER RESEARCH, 2016, 76
  • [45] ETS transcription factors and prostate cancer: The role of the family prototype ETS-1
    Shaikhibrahim, Zaki
    Wernert, Nicolas
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) : 1748 - 1754
  • [46] ETS2 Loss of Expression in Prostate Cancer
    Segales Tana, Laura
    Lloreta-Trull, Josep
    Juanpere-Rodero, Nuria
    Lorenzo, Marta
    Fumado, Lluis
    Cecchini, Lluis
    Hernandez-Llodra, Silvia
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 969 - 969
  • [47] Testing mutual exclusivity of ETS rearranged prostate cancer
    Svensson, Maria A.
    LaFargue, Christopher J.
    MacDonald, Theresa Y.
    Pflueger, Dorothee
    Kitabayashi, Naoki
    Santa-Cruz, Ashley M.
    Garsha, Karl E.
    Sathyanarayana, Ubaradka G.
    Riley, Janice P.
    Yun, Chol S.
    Nagy, Dea
    Kosmeder, Jerry W.
    Pestano, Gary A.
    Tewari, Ashutosh K.
    Demichelis, Francesca
    Rubin, Mark A.
    LABORATORY INVESTIGATION, 2011, 91 (03) : 404 - 412
  • [48] Testing Mutual Exclusivity of ETS Rearranged Prostate Cancer
    Svensson, M. A.
    LaFargue, C. J.
    Pflueger, D.
    Kitabayashi, N.
    Tewari, A. K.
    Demichelis, F.
    Rubin, M. A.
    MODERN PATHOLOGY, 2010, 23 : 221A - 221A
  • [49] Testing Mutual Exclusivity of ETS Rearranged Prostate Cancer
    Svensson, M. A.
    LaFargue, C. J.
    Pflueger, D.
    Kitabayashi, N.
    Tewari, A. K.
    Demichelis, F.
    Rubin, M. A.
    LABORATORY INVESTIGATION, 2010, 90 : 221A - 221A
  • [50] ETS2 Loss of Expression in Prostate Cancer
    Tana, Laura Segales
    Lloreta-Trull, Josep
    Juanpere-Rodero, Nuria
    Lorenzo, Marta
    Fumado, Lluis
    Cecchini, Lluis
    Hernandez-Llodra, Silvia
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 969 - 969
12345